A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

Inclusion Criteria: * Aged between 19 and 79 years old at screening visit * Subjects who have being used anti-hypertension drugs and Lipid lowering agents over 4weeks before randomization. * Subjects who have been diagnosed with metabolic syndrome according to following criteria Definition of patients with metabolic syndrome: Patients satisfy two of the following criteria at least * Abdominal obesity: Waist measurement \> 90 cm(male), \> 80 cm(female) * Triglyceride(TG) ≥ 150 mg/dL( * High-Density Lipoprotein Cholesterol(HDL-C) \< 40 mg/dL(male), \< 50 mg/dL (female) * Fasting Plasma Glucose(FPG) ≥ 100 mg/dL or Subject who has being used oral hypoglycemic agents * Childbearing potential women have certainly negative of the pregnancy test at screening visit (visit 1), and agree to implement the effective contraception during the study period(including the medically non-pregnant state) * Subjects who have signed after fully understanding the purpose, content, characteristics and risk of the investigational product and get explained enough. Exclusion Criteria: * Subjects who taking anti-hypertension drugs more than three agent * Subjects who have mean Sitting Systolic Blood Pressure(siSBP) \> 160 mmHg (excluded if appliable, one of the arms) * Subjects who have blood pressure ≥ 140/90 mmHg with taking 2 or more anti-hypertension drugs (except if any of the arms) * Subjects that Low Density Lipoprotein-Cholesterol(LDL-C) isn't properly controlled according to National Cholesterol Education Program Adults Treatment Panel (NCEP ATP) III criteria * Subjects who have triglyceride (TG) ≥ 400mg/dL * Subjects who have a difference more than 20mmHg at the mean Sitting Diastolic Blood Pressure(siSBP) measured three times in both arms. * Other exclusions applied